BYND vs RARE · rev $127.0M vs rev $350.0M
Beyond Meat Inc (BYND) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Beyond Meat Inc (BYND) is a packaged foods company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported BYND revenue for 2026-06-27 was $127.0M. Net income was -$12.1M. BYND currently screens at market cap $266.9M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
BYND currently screens at market cap $266.9M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the BYND and RARE stock pages for the full models.
Not investment advice.